Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedApr 01, 2026
DataAggregated Company Financials
Companies9
- 7D4.1%
- 3M-4.3%
- 1Y11.1%
- YTDn/a
In the last week, the Pharma industry is up 4.1%, with Merck KGaA leading the way, up 4.1%. This means that the industry has gained 11% over the past year. As for the next few years, earnings are expected to grow by 29% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 01 Apr 2026 | €88.3b | €67.9b | -€900,258,104.98 | 18.8x | -98.1x | 1.3x |
| Fri, 27 Feb 2026 | €98.3b | €68.3b | €2.9b | 18.4x | 34.3x | 1.4x |
| Sun, 25 Jan 2026 | €102.0b | €68.3b | €2.9b | 17.7x | 35.6x | 1.5x |
| Tue, 23 Dec 2025 | €89.9b | €68.3b | €2.9b | 17.5x | 31.4x | 1.3x |
| Thu, 20 Nov 2025 | €77.7b | €68.5b | €2.9b | 16.4x | 27x | 1.1x |
| Sat, 18 Oct 2025 | €78.1b | €68.8b | -€439,012,678.07 | 19.5x | -178x | 1.1x |
| Mon, 15 Sep 2025 | €77.1b | €68.9b | -€406,210,674.83 | 17x | -189.7x | 1.1x |
| Wed, 13 Aug 2025 | €76.8b | €68.9b | -€409,994,651.97 | 16.9x | -187.4x | 1.1x |
| Fri, 11 Jul 2025 | €79.5b | €69.4b | -€283,071,598.00 | 17.9x | -281x | 1.1x |
| Sun, 08 Jun 2025 | €78.7b | €69.4b | -€207,525,074.95 | 18.5x | -379x | 1.1x |
| Tue, 06 May 2025 | €81.2b | €69.3b | €463.8m | 19.2x | 175x | 1.2x |
| Thu, 03 Apr 2025 | €78.4b | €69.2b | €443.8m | 20.8x | 176.7x | 1.1x |
| Sat, 01 Mar 2025 | €83.8b | €69.2b | €2.0b | 21.9x | 41.4x | 1.2x |
| Mon, 27 Jan 2025 | €86.4b | €69.2b | €2.0b | 23.4x | 43x | 1.2x |
| Wed, 25 Dec 2024 | €81.1b | €69.2b | €2.0b | 22.2x | 40.4x | 1.2x |
| Fri, 22 Nov 2024 | €81.9b | €69.2b | €2.0b | 22.3x | 40.5x | 1.2x |
| Sun, 20 Oct 2024 | €99.9b | €69.4b | €1.6b | 21.1x | 64x | 1.4x |
| Tue, 17 Sep 2024 | €100.9b | €69.3b | €1.5b | 25.2x | 68.5x | 1.5x |
| Thu, 15 Aug 2024 | €100.5b | €69.3b | €1.5b | 30.8x | 69x | 1.5x |
| Sat, 13 Jul 2024 | €96.1b | €69.2b | -€303,627,757.00 | 29.4x | -316.3x | 1.4x |
| Mon, 10 Jun 2024 | €104.7b | €69.2b | -€328,028,608.00 | 20.5x | -319.1x | 1.5x |
| Wed, 08 May 2024 | €97.2b | €70.0b | -€71,426,169.16 | 20.2x | -1361.2x | 1.4x |
| Fri, 05 Apr 2024 | €98.0b | €70.0b | -€34,208,180.00 | 20.8x | -2865.8x | 1.4x |
| Sun, 03 Mar 2024 | €99.2b | €70.6b | -€650,504,143.00 | 19.8x | -152.5x | 1.4x |
| Tue, 30 Jan 2024 | €99.7b | €70.6b | -€647,396,793.00 | 22.1x | -154x | 1.4x |
| Thu, 28 Dec 2023 | €97.7b | €70.6b | -€650,606,256.00 | 19.3x | -150.2x | 1.4x |
| Sat, 25 Nov 2023 | €104.6b | €70.6b | -€653,407,256.00 | 19.8x | -160.2x | 1.5x |
| Mon, 23 Oct 2023 | €108.0b | €72.1b | €4.7b | 18.1x | 23.1x | 1.5x |
| Wed, 20 Sep 2023 | €119.3b | €72.1b | €4.7b | 21.8x | 25.5x | 1.7x |
| Fri, 18 Aug 2023 | €123.3b | €72.1b | €4.7b | 22.6x | 26.3x | 1.7x |
| Sun, 16 Jul 2023 | €117.4b | €74.1b | €6.5b | 18.2x | 18.2x | 1.6x |
| Tue, 13 Jun 2023 | €126.9b | €74.1b | €6.4b | 22.7x | 19.8x | 1.7x |
| Thu, 11 May 2023 | €130.4b | €74.2b | €7.6b | 21.1x | 17.2x | 1.8x |
| Sat, 08 Apr 2023 | €139.0b | €74.2b | €7.6b | 19.7x | 18.2x | 1.9x |
Price to Earnings Ratio
18.2x
Current Industry PE
- Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 2.9% per year, which is driving profits down.
Industry Comparison
How does German Pharma compare with similar industries?
| DE Market | 0.20% | |
| Healthcare | 1.67% | |
| Pharma | 4.11% | |
| Pharma | 4.11% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MRK Merck KGaA | €107.60 | 4.1% +€1.8b | -15.0% | PE17.9x | |
| BAYN Bayer | €39.39 | 4.4% +€1.6b | 76.5% | PS0.8x | |
| DMP Dermapharm Holding | €42.30 | 1.2% +€26.9m | 15.9% | PE19.6x | |
| 93M1 MPH Health Care | €18.20 | 1.4% +€1.1m | -19.5% | PB0.4x | |
| B8FK Biofrontera | €2.59 | 0.8% +€121.5k | 4.2% | PS0.7x |
